283 related articles for article (PubMed ID: 26272810)
21. beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.
Cosgrove KP; Batis J; Bois F; Maciejewski PK; Esterlis I; Kloczynski T; Stiklus S; Krishnan-Sarin S; O'Malley S; Perry E; Tamagnan G; Seibyl JP; Staley JK
Arch Gen Psychiatry; 2009 Jun; 66(6):666-76. PubMed ID: 19487632
[TBL] [Abstract][Full Text] [Related]
22. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
[TBL] [Abstract][Full Text] [Related]
23. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).
Pichika R; Easwaramoorthy B; Christian BT; Shi B; Narayanan TK; Collins D; Mukherjee J
Nucl Med Biol; 2011 Nov; 38(8):1183-92. PubMed ID: 21831652
[TBL] [Abstract][Full Text] [Related]
24. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
[TBL] [Abstract][Full Text] [Related]
25. Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.
Brody AL; Mukhin AG; Stephanie Shulenberger ; Mamoun MS; Kozman M; Phuong J; Neary M; Luu T; Mandelkern MA
Neuropsychopharmacology; 2013 Jul; 38(8):1548-56. PubMed ID: 23429692
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
[TBL] [Abstract][Full Text] [Related]
27. Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
Fujita M; Tamagnan G; Zoghbi SS; Al-Tikriti MS; Baldwin RM; Seibyl JP; Innis RB
J Nucl Med; 2000 Sep; 41(9):1552-60. PubMed ID: 10994738
[TBL] [Abstract][Full Text] [Related]
28. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
[TBL] [Abstract][Full Text] [Related]
30. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
31. 123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase.
Cosgrove KP; Mitsis EM; Bois F; Frohlich E; Tamagnan GD; Krantzler E; Perry E; Maciejewski PK; Epperson CN; Allen S; O'malley S; Mazure CM; Seibyl JP; van Dyck CH; Staley JK
J Nucl Med; 2007 Oct; 48(10):1633-40. PubMed ID: 17873128
[TBL] [Abstract][Full Text] [Related]
32. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
Meyer PM; Strecker K; Kendziorra K; Becker G; Hesse S; Woelpl D; Hensel A; Patt M; Sorger D; Wegner F; Lobsien D; Barthel H; Brust P; Gertz HJ; Sabri O; Schwarz J
Arch Gen Psychiatry; 2009 Aug; 66(8):866-77. PubMed ID: 19652126
[TBL] [Abstract][Full Text] [Related]
33. Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
Horti AG; Kuwabara H; Holt DP; Dannals RF; Wong DF
J Labelled Comp Radiopharm; 2013; 56(3-4):159-66. PubMed ID: 24285321
[TBL] [Abstract][Full Text] [Related]
34. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
[TBL] [Abstract][Full Text] [Related]
35.
Coughlin JM; Slania S; Du Y; Rosenthal HB; Lesniak WG; Minn I; Smith GS; Dannals RF; Kuwabara H; Wong DF; Wang Y; Horti AG; Pomper MG
J Nucl Med; 2018 Oct; 59(10):1603-1608. PubMed ID: 29496987
[TBL] [Abstract][Full Text] [Related]
36. Trapping of Nicotinic Acetylcholine Receptor Ligands Assayed by
Zhang HJ; Zammit M; Kao CM; Govind AP; Mitchell S; Holderman N; Bhuiyan M; Freifelder R; Kucharski A; Zhuang X; Mukherjee J; Chen CT; Green WN
J Neurosci; 2023 Jan; 43(1):2-13. PubMed ID: 36028313
[TBL] [Abstract][Full Text] [Related]
37. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
[TBL] [Abstract][Full Text] [Related]
38. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
[TBL] [Abstract][Full Text] [Related]
39. A positive relationship between harm avoidance and brain nicotinic acetylcholine receptor availability.
Storage S; Mandelkern MA; Phuong J; Kozman M; Neary MK; Brody AL
Psychiatry Res; 2013 Dec; 214(3):415-21. PubMed ID: 24148908
[TBL] [Abstract][Full Text] [Related]
40. Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects.
Faulkner P; Ghahremani DG; Tyndale RF; Cox CM; Kazanjian AS; Paterson N; Lotfipour S; Hellemann GS; Petersen N; Vigil C; London ED
Neuropsychopharmacology; 2017 Jul; 42(8):1610-1618. PubMed ID: 28117337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
